Akihiro Tsuchimoto

Akihiro Tsuchimoto

Auto-generated profile, based on publicly available information

Akihiro Tsuchimoto

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Transplantation
Verified
Journal Article
Closed access
KMKosuke Masutani
Kosuke Masutani
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
KKKei Kurihara
Kei Kurihara
YOYasuhiro Okabe
Yasuhiro Okabe
HKHidehisa Kitada
Hidehisa Kitada
Kazuhiko TsuruyaKazuhiko Tsuruya
Kazuhiko Tsuruya
Analyses using 3- and 12-month PBs suggested comparable allograft pathology between ABO-C and ABO-I KTx under desensitization with low-dose rituximab and plasmapheresis.

2 June 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
KNKaneyasu Nakagawa
Kaneyasu Nakagawa
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
KUKenji Ueki
Kenji Ueki
YMYuta Matsukuma
Yuta Matsukuma
YOYasuhiro Okabe
Yasuhiro Okabe
JIJapan Academic Consortium of Kidney Transplantation Investigators
Japan Academic Consortium of Kidney Transplantation Investigators
Diagnostic criteria for chronic active T‐cell mediated rejection (CA‐TCMR) were revised in the Banff 2017 consensus, but it is unknown whether the new criteria predict graft prognosis of kidney transplantation. We enrolled 406 kidney allograft recipients who underwent a 1‐year protocol biopsy (PB) and investigated the diagnostic significance of Banff 2017. Interobserver reproducibility of the three diagnosticians showed a substantial agreement rate of 0.68 in Fleiss’s kappa coefficient. Thirty‐three patients (8%) were classified as CA‐TCMR according to Banff 2017, and 6 were previously diagnosed as normal, 12 as acute TCMR, 10 with borderline changes, and 5 as CA‐TCMR according to Banff 2015 criteria. Determinant factors of CA‐TCMR were cyclosporine use (vs. tacrolimus), previous acute rejection, and BK polyomavirus‐associated nephropathy. In survival analysis, the new diagnosis of CA‐TCMR predicted a composite graft endpoint defined as doubling serum creatinine or death‐censored graft loss (log‐rank test, P <0.001). In multivariate analysis, CA‐TCMR was associated with the second highest risk of the composite endpoint (hazard ratio: 5.42; 95% confidence interval, 2.02–14.61; P <0.001, vs. normal) behind antibody‐mediated rejection. In conclusion, diagnosis of CA‐TCMR in Banff 2017 may facilitate detecting an unfavorable prognosis of kidney allograft recipients who undergo a 1‐year PB.

11 January 2019 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
YMYuta Matsukuma
Yuta Matsukuma
KUKenji Ueki
Kenji Ueki
STShigeru Tanaka
Shigeru Tanaka
KMKosuke Masutani
Kosuke Masutani
TKTakanari Kitazono
Takanari Kitazono
Background: The utility of the Columbia classification (Col-class) for focal segmental glomerulosclerosis (FSGS) has not yet been fully proven. Methods: We extracted 201 FSGS patients from 10 nephrology centers in Japan and investigated the difference of a composite renal endpoint, defined as doubling of serum creatinine and/or development of end-stage renal disease, in pathological variants. Sensitivity analysis was used to prove the utility of the Col-class to predict renal outcomes. Additionally, the renal protective effects of steroids and/or immunosuppression (steroid/IS) were investigated in patients stratified according to the Col-class. Results: The patients were classified into the following variants: not otherwise specified [NOS; n = 121 (60.1%)], perihilar [n = 31 (15.4%)], cellular [n = 19 (9.5%)], tip [n = 17 (8.5%)] and collapsing [n = 13 (6.5%)]. No tip variant patients reached the renal endpoint. The renal outcome in the collapsing variant was significantly poorer than that in the NOS [hazard ratio (HR) 3.71; P = 0.005]. In the sensitivity analysis, the area under the receiver operating characteristic curve for the renal endpoint was increased by adding Col-class to a model including common risk factors (P = 0.021). In a subgroup treated without steroid/IS, the outcome in the cellular variant was worse than that in the NOS (HR 5.10; P = 0.040) but the difference was not observed in the subgroup with steroid/IS (HR 0.54; P = 0.539). Conclusions: The Col-class is useful to predict renal prognosis in Japanese patients with FSGS. In addition to good prognosis in the tip variant and poor in the collapsing variant, good clinical course in the cellular variant treated with steroid/IS was suggested.

21 October 2016 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
TNToshiaki Nakano
Toshiaki Nakano
SHShoko Hasegawa
Shoko Hasegawa
KMKosuke Masutani
Kosuke Masutani
YMYuta Matsukuma
Yuta Matsukuma
Kazuhiko TsuruyaKazuhiko Tsuruya
Kazuhiko Tsuruya

14 September 2013 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
KMKosuke Masutani
Kosuke Masutani
NHNaoki Haruyama
Naoki Haruyama
MNMasaharu Nagata
Masaharu Nagata
HNHideko Noguchi
Hideko Noguchi
TKTakanari Kitazono
Takanari Kitazono
Background/Aims: Anemia is common in kidney transplant patients and may cause adverse cardiovascular events. Several studies have reported some predictors of post-transplant anemia. However, associations between the pathological findings in the 0-hour biopsy and anemia have not been well described. Methods: 258 consecutive kidney transplant patients were enrolled in this retrospective study. The patients were divided into two groups, according to the presence or absence of interstitial fibrosis and tubular atrophy (IF/TA) in the 0-hour biopsy: the IF/TA group with fibrotic area ≥5% (n = 131) and the non-IF/TA group with fibrotic area <5% (n = 127). We examined the association between IF/TA and post-transplant anemia. Results: Serial changes in hemoglobin levels in the IF/TA group were lower than in the non-IF/TA group (p = 0.007). Anemia at 12 months was found in 53% of the IF/TA group, and 35% of the non-IF/TA group (p = 0.004). Even after adjustment for several confounders including graft function, the presence of IF/TA was independently associated with post-transplant anemia at 12 months (odds ratio 1.88, 95% confidence interval 1.06-3.36, p = 0.031). This association was still significant in a subgroup with normal graft function. Conclusions: IF/TA in the 0-hour biopsy specimen is one of the predictors for post-transplant anemia and can be used to identify patients who need the treatment with erythropoiesis-stimulating agents.

2 July 2018 in Nephrology
Verified
Journal Article
Closed access
PDF file
YMYuta Matsukuma
Yuta Matsukuma
KMKosuke Masutani
Kosuke Masutani
ATAkihiro Tsuchimoto
Akihiro Tsuchimoto
YOYasuhiro Okabe
Yasuhiro Okabe
MNMasafumi Nakamura
Masafumi Nakamura
Kazuhiko TsuruyaKazuhiko Tsuruya
Kazuhiko Tsuruya